These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23291370)

  • 21. High-calcium dialysate: a factor associated with inflammation, malnutrition and mortality in non-diabetic maintenance haemodialysis patients.
    Hsu CW; Lin JL; Lin-Tan DT; Yen TH; Chen KH; Huang WH; Ho TC; Huang YL
    Nephrology (Carlton); 2010 Apr; 15(3):313-20. PubMed ID: 20470300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of dialysis purity on uremic dyslipidemia.
    Schiffl H; Lang SM
    Ther Apher Dial; 2010 Feb; 14(1):5-11. PubMed ID: 20438514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of ultrafiltered dialysate is associated with improvements in haemodialysis-associated morbidity in patients treated with reused dialysers.
    Ouseph R; Jones S; Dhananjaya N; Ward RA
    Nephrol Dial Transplant; 2007 Aug; 22(8):2269-75. PubMed ID: 17400564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations between immunologic, inflammatory, and oxidative stress markers with severity of depressive symptoms: an analysis of the 2005-2006 National Health and Nutrition Examination Survey.
    Kobrosly R; van Wijngaarden E
    Neurotoxicology; 2010 Jan; 31(1):126-33. PubMed ID: 19853625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of serum albumin level on iron-induced oxidative stress in chronic renal failure patients.
    Sezer MT; Akin H; Demir M; Erturk J; Aydin ZD; Savik E; Tunc N
    J Nephrol; 2007; 20(2):196-203. PubMed ID: 17514624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultrapure dialysate decreases plasma pentosidine, a marker of "carbonyl stress".
    Izuhara Y; Miyata T; Saito K; Ishikawa N; Kakuta T; Nangaku M; Yoshida H; Saito A; Kurokawa K; van Ypersele de Strihou C
    Am J Kidney Dis; 2004 Jun; 43(6):1024-9. PubMed ID: 15168382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Nutritional status evaluation in maintenance hemodialysis patients].
    Segall L; Covic A; Mardare N; Ungureanu S; Marian S; Busuioc M; Nistor I; Enache R; Veisa G; Covic M
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(2):343-50. PubMed ID: 19295002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of unsaturated fat dietary supplements on blood lipids, and on markers of malnutrition and inflammation in hemodialysis patients.
    Ewers B; Riserus U; Marckmann P
    J Ren Nutr; 2009 Sep; 19(5):401-11. PubMed ID: 19541503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation of ultrapure dialysate in Japan--clinical usefulness and short-term future.
    Sato T; Kurosawa A; Kurihara T; Kurosawa T
    Blood Purif; 2004; 22 Suppl 2():55-9. PubMed ID: 15655325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of acetate-free citrate-containing dialysate on metabolic acidosis, anemia, and malnutrition in hemodialysis patients.
    Kuragano T; Kida A; Furuta M; Yahiro M; Kitamura R; Otaki Y; Nonoguchi H; Matsumoto A; Nakanishi T
    Artif Organs; 2012 Mar; 36(3):282-90. PubMed ID: 21954915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of grape seed extract in Type 2 diabetic subjects at high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity.
    Kar P; Laight D; Rooprai HK; Shaw KM; Cummings M
    Diabet Med; 2009 May; 26(5):526-31. PubMed ID: 19646193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of C-reactive protein in patients on hemodialysis: a longitudinal study.
    Teruel JL; Marcen R; Ocaña J; Fernández-Lucas M; Rivera M; Tabernero G; Ortuño J
    Nephron Clin Pract; 2005; 100(4):c140-5. PubMed ID: 15855797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of high-dose thiamine and pyridoxine on advanced glycation end products and other oxidative stress markers in hemodialysis patients: a randomized placebo-controlled study.
    Nascimento MM; Suliman ME; Murayama Y; Nihi M; Hayashi SY; Stenvinkel P; Riella MC; Lindholm B
    J Ren Nutr; 2006 Apr; 16(2):119-24. PubMed ID: 16567267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
    Pellicano R; Polkinghorne KR; Kerr PG
    Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predialysis serum sodium level, dialysate sodium, and mortality in maintenance hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Hecking M; Karaboyas A; Saran R; Sen A; Hörl WH; Pisoni RL; Robinson BM; Sunder-Plassmann G; Port FK
    Am J Kidney Dis; 2012 Feb; 59(2):238-48. PubMed ID: 21944663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of vitamin E-coated membrane dialyser on markers of oxidative stress and inflammation in patients on chronic haemodialysis.
    Kirmizis D; Papagianni A; Belechri AM; Memmos D
    Nephrol Dial Transplant; 2011 Jul; 26(7):2296-301. PubMed ID: 21127134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients.
    Himmelfarb J; Phinney S; Ikizler TA; Kane J; McMonagle E; Miller G
    J Ren Nutr; 2007 Sep; 17(5):296-304. PubMed ID: 17720098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between residual renal function, inflammation, and anemia in peritoneal dialysis.
    Pérez-Flores I; Coronel F; Cigarrán S; Herrero JA; Calvo N
    Adv Perit Dial; 2007; 23():140-3. PubMed ID: 17886621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Nutritional status, comorbidity, and inflammation in hemodialysis].
    Fernández-Reyes MJ; Alvarez-Ude F; Sánchez R; Mon C; Iglesias P; Vázquez A
    Nefrologia; 2000; 20(6):540-9. PubMed ID: 11217649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N; Osman-Malik Y; Frinak S; Besarab A
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.